Engineered strategies for the allergic disease therapy
Yun Tian,
No information about this author
Xin Wu,
No information about this author
Xiaoqi Sun
No information about this author
et al.
Deleted Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 9, 2025
Abstract
Allergic
diseases
with
high
recurrence
rates
have
severely
threatened
human
health
around
the
world.
Several
strategies
been
developed
including
administration
of
allergens
or
neutralizing
antibodies,
while
allergen‐specific
immunotherapy
(AIT)
has
considered
as
a
cure
for
allergic
diseases.
However,
AIT
some
drawbacks
anaphylactic
side
effects
native
allergen
protein
during
therapy,
poor
biodistribution
in
targeted
organs/cells,
and
unsatisfactory
desensitization
long‐term
unresponsiveness
after
treatment.
Biomaterials
hydrogels,
nanoparticles,
polymers
nanoemulsions
could
improve
pharmacokinetics
avoid
leakage
free
allergens,
thereby
improving
therapeutic
efficacy
reduced
effects.
This
review
summarizes
recent
advances
engineered
biomaterials
to
alleviate
diseases,
especially
combination
AIT.
Due
prevalence
various
very
limited
therapeutics
patients,
this
will
provide
new
insights
into
development
novel
prevention
treatment
sustained
unresponsiveness.
Language: Английский
Altered mitochondrial mass and low mitochondrial membrane potential of immune cells in patients with HBV infection and correlation with liver inflammation
Liling Ma,
No information about this author
Qingzhen Han,
No information about this author
Longji Cheng
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 22, 2024
Mitochondrial
membrane
potential
(MMP)
and
mitochondrial
mass
(MM)
affect
function
lymphocyte
activation,
but
few
studies
on
HBV
infection
exist.
This
study
aimed
to
investigate
the
regulatory
mechanism
of
dysfunction
during
its
clinical
significance
by
analyzing
alterations
MM
MMP
Language: Английский